Loading...

FGEN FIBROGEN INC Disposals and divestitures 8-K Filing

FBRG

FGN

FIBROGEN INC

(FGEN)

2025 8-K

Financial Results Released

Payment Received

Asset Sale Completed

Acquisition Announcement

Financing Agreement Update

Debt-Equity Swaps

Divestment of Assets

Reverse Stock Split

Financial Statements

Bylaw Amendment

Drug Publication

Agreement Amendments

Financial Update

Equity Offering

Management Change

Q3 Financial Results

Lease Termination

Director Resignations

Executive Departures

Restructuring Plan

Financial Results and Busin...

Investor Presentation

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Delisting Notice

Appointment of CEO and Dire...

Resignation of Chief Medica...

Financial Results Announcement

Appointments, resignations

Management changes

Annual Meeting of Stockholders

Positive Results from Phase...

Financial Results Announcement

Financing Agreement

External Links:

On November 6, 2025, FibroGen, Inc. received a $6.4 million payment from AstraZeneca as part of a share purchase agreement related to the sale of its China operations, which closed on August 29, 2025.

AI Assistant

FIBROGEN INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.